IDIBAPS, Institut d'Investigacions Biomèdiques August Pi i Sunyer

Resultats de l'any: 2010 2009 2008 2007

Factor d'impacte: mitjana: 5.76, total: 316.95

Articles de l'any 2010

Original

• Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

  Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA
  ANN RHEUM DIS. 2010; 69: 20-28. IF: 8.111

• The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

  Houssiau FA, Vasconcelos C, D'cruz D, Sebastiani GD, Garrido ED, Danieli MG, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R
  ANN RHEUM DIS. 2010; 69: 61-64. IF: 8.111

• Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events

  Lozano E, Segarra M, Corbera-Bellalta M, Garcia-Martinez A, Espigol-Frigole G, Pla-Campo A, Hernandez-Rodriguez J, Cid MC
  ANN RHEUM DIS. 2010; 69: 434-442. IF: 8.111

• Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

  Houssiau FA, D'cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, Garrido ED, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, LeGuern V, Depresseux G, Guillevin L, Cervera R
  ANN RHEUM DIS. 2010; 69: 2083-2089. IF: 8.111

• Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

  Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcon GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Ginzler E, Bruce IN, Steinsson K, Khamashta M, Petri M, Manzi S, Dooley MA, Ramsey-Goldman R, VanVollenhoven R, Nived O, Sturfelt G, Aranow C, Kalunian K, Ramos-Casals M, Zoma A, Douglas J, Thompson K, Farewell V
  ANN RHEUM DIS. 2010; 69: 529-535. IF: 8.111

• Failure of Intravenous Immunoglobulin to Prevent Congenital Heart Block Findings of a Multicenter, Prospective, Observational Study

  Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, Sanchez-Roman J, Garcia-Hernandez FG, Tincani A, Bertero MT, Doria A, Hughes GRV, Khamashta MA
  ARTHRITIS RHEUM-US. 2010; 62: 1147-1152. IF: 7.332

• Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways

  Segarra M, Lozano E, Corbera-Bellalta M, Vilardell C, Cibeira MT, Esparza J, Izco N, Blade J, Cid MC
  HAEMATOL-HEMATOL J. 2010; 95: 456-463. IF: 6.416

• The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus

  Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R
  AUTOIMMUN REV. 2010; 10: 108-111. IF: 6.368

• Factors influencing polyautoimmunity in systemic lupus erythematosus

  Rojas-Villarraga A, Toro CE, Espinosa G, Rodriguez-Velosa Y, Duarte-Rey C, Mantilla RD, Iglesias-Gamarra A, Cervera R, Anaya JM
  AUTOIMMUN REV. 2010; 9: 229-232. IF: 6.368

• Etiopathogenesis of Behcet's disease

  Mendoza-Pinto C, Garcia-Carrasco M, Jimenez-Hernandez M, Hernandez CJ, Riebeling-Navarro C, Zavala AN, Recabarren MV, Espinosa G, Quezada JJ, Cervera R
  AUTOIMMUN REV. 2010; 9: 241-245. IF: 6.368

• Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus

  Quintana G, Coral-Alvarado P, Aroca G, Patarroyo PM, Chalem P, Iglesias-Gamarra A, Ruiz AI, Cervera R
  AUTOIMMUN REV. 2010; 9: 750-755. IF: 6.368

• Outcomes in Biopsy-Proven Lupus Nephritis Evaluation of 190 White Patients From a Single Center

  Siso A, Ramos-Casals M, Bove A, Brito-Zeron P, Soria N, Nardi N, Testi A, Perez-De-Lis M, Diaz-Lagares C, Darnell A, Sentis J, Coca A
  MEDICINE. 2010; 89: 300-307. IF: 5.054

• Transverse Myelitis Affecting More Than 4 Spinal Segments Associated with Systemic Lupus Erythematosus: Clinical, Immunological, and Radiological Characteristics of 22 Patients

  Espinosa G, Mendizabal A, Minguez S, Ramo-Tello C, Capellades J, Olive A, Cervera R
  SEMIN ARTHRITIS RHEU. 2010; 39: 246-256. IF: 4.724

• Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients

  Vera-Recabarren MA, Garcia-Carrasco M, Ramos-Casals M, Herrero C
  BRIT J DERMATOL. 2010; 162: 91-101. IF: 4.26

• Comparison of IVF cycles reported in a voluntary ART registry with a mandatory registry in Spain

  Luceno F, Castilla JA, Gomez-Palomares JL, Cabello Y, Hernandez J, Marqueta J, Herrero J, Vidal E, Fernandez-Shaw S, Coroleu B
  HUM REPROD. 2010; 25: 3066-3071. IF: 3.859

• Clinical and Prognostic Significance of Parotid Scintigraphy in 405 Patients with Primary Sjogren's Syndrome

  Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Diaz-Lagares C, Bove A, Soto MJ, Jimenez I, Belenguer R, Siso A, Muxi A, Pons F
  J RHEUMATOL. 2010; 37: 585-590. IF: 3.854

• Treatment of Primary Sjogren Syndrome A Systematic Review

  Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X
  JAMA-J AM MED ASSOC. 2010; 304: 452-460. IF: 28.899

• Systemic lupus erythematosus

  O'neill S, Cervera R
  BEST PRACT RES CL RH. 2010; 24: 841-855. IF: 2.904

• Case Report: Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus

  Pinazo MJ, Espinosa G, Gallego M, Lopez-Chejade PL, Urbina JA, Gascon J
  AM J TROP MED HYG. 2010; 82: 583-587. IF: 2.795

• Sjogren Syndrome or Sjogren Disease? The Histological and Immunological Bias Caused by the 2002 Criteria

  Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, Soto MJ, Akasbi M, Diaz C, Sentis J, Siso A
  CLIN REV ALLERG IMMU. 2010; 38: 178-185. IF: 2.597

• Cardiovascular risk factors in primary Sjogren's syndrome: a case-control study in 624 patients

  Perez-De-Lis M, Akasbi M, Siso A, Diez-Cascon P, Brito-Zeron P, Diaz-Lagares C, Ortiz J, Perez-Alvarez R, Ramos-Casals M, Coca A
  LUPUS. 2010; 19: 941-948. IF: 2.586

• Prolactin's role in the pathogenesis of the antiphospholipid syndrome

  Praprotnik S, Agmon-Levin N, Porat-Katz BS, Blank M, Meroni PL, Cervera R, Miesbach W, Stojanovich L, Szyper-Kravitz M, Rozman B, Tomsic M, Shoenfeld Y
  LUPUS. 2010; 19: 1515-1519. IF: 2.586

• Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies

  Martinez-Zamora MA, Tassies D, Carmona F, Espinosa G, Cerverac R, Reverter JC, Balasch J
  J REPROD IMMUNOL. 2010; 86: 133-140. IF: 2.519

• Effects of caffeine and glucose, alone and combined, on cognitive performance

  Adan A, Serra-Grabulosa JM
  HUM PSYCHOPHARM CLIN. 2010; 25: 310-317. IF: 2.496

• Glucose and caffeine effects on sustained attention: an exploratory fMRI study

  Serra-Grabulosa JM, Adan A, Falcon C, Bargallo N
  HUM PSYCHOPHARM CLIN. 2010; 25: 543-552. IF: 2.496

• Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases

  Colli A, Mestres CA, Espinosa G, Plasin MA, Pomar JL, Font J, Cervera R
  EUR J CARDIO-THORAC. 2010; 37: 154-158. IF: 2.397

• Bronchiectasis in primary Sjogren's syndrome: prevalence and clinical significance

  Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, Gandia M, Akasbi M, Siso A, Ballester E, Torres A, Ramos-Casals M
  CLIN EXP RHEUMATOL. 2010; 28: 647-653. IF: 2.396

• Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases

  Ramos-Casals M, Garcia-Hernandez FJ, DeRamon E, Callejas JL, Martinez-Berriotxoa A, Pallares L, Caminal-Montero L, Selva-O'callaghan A, Oristrell J, Hidalgo C, Perez-Alvarez R, Mico ML, Medrano F, Gomez-De-La-Torre R, Diaz-Lagares C, Camps M, Ortego N, Sanchez-Roman J
  CLIN EXP RHEUMATOL. 2010; 28: 468-476. IF: 2.396

• Genotypes Coding for Low Serum Levels of Mannose-Binding Lectin Are Underrepresented among Individuals Suffering from Noninfectious Systemic Inflammatory Response Syndrome

  Smithson A, Perello R, Aibar J, Espinosa G, Tassies D, Freire C, Castro P, Suarez B, Lozano F, Nicolas JM
  CLIN VACCINE IMMUNOL. 2010; 17: 447-453. IF: 2.373

• BELIMUMAB, A BLyS-SPECIFIC INHIBITOR FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

  Espinosa C, Cervera R
  DRUG TODAY. 2010; 46: 891-899. IF: 1.588

• Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender

  Vera-Recabarren MA, Garcia-Carrasco M, Ramos-Casals M, Herrero C
  CLIN EXP DERMATOL. 2010; 35: 729-735. IF: 1.55

Revisió

• Autoimmune diseases induced by biological agents A double-edged sword?

  Ramos-Casals M, ROBERTO-PEREZ-ALVAREZ, Diaz-Lagares C, Cuadrado MJ, Khamashta MA
  AUTOIMMUN REV. 2010; 9: 188-193. IF: 6.368

• Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

  Erkan D, Espinosa G, Cervera R
  AUTOIMMUN REV. 2010; 10: 74-79. IF: 6.368

• Surgical interventions and local therapy for Wegener's granulomatosis

  Hernandez-Rodriguez J, Hoffman GS, Koening CL
  CURR OPIN RHEUMATOL. 2010; 22: 29-36. IF: 4.6

• Autoimmunity and Recurrent Pregnancy Losses

  Cervera R, Balasch J
  CLIN REV ALLERG IMMU. 2010; 39: 148-152. IF: 2.597

• Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'

  Cervera R
  LUPUS. 2010; 19: 412-418. IF: 2.586

• RECENT TRENDS IN THE MANAGEMENT OF ANTIPHOSPHOLIPID SYNDROME (HUGHES SYNDROME)

  Espinosa G, Cervera R
  DRUG TODAY. 2010; 46: 39-47. IF: 1.588

• Neural bases of numerical processing and calculation

  Serra-Grabulosa JM, Adan A, Perez-Pamies M, Lachica J, Membrives S
  REV NEUROLOGIA. 2010; 50: 39-46. IF: 1.234

Editorials

• Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies

  Cervera R, Espinosa G
  EXPERT OPIN THER TAR. 2010; 14: 1279-1282. IF: 3.713

Multicèntrics

• Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis

  Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA
  ARTHRITIS RHEUM-US. 2010; 62: 211-221. IF: 7.332

Guies clíniques

• EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

  Bertsias GK, Ioannidis JPA, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TWJ, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, VanBuchem MA, VanVollenhoven R, Ward M, Gordon C, Boumpas DT
  ANN RHEUM DIS. 2010; 69: 2074-2082. IF: 8.111

• EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

  Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, DeGroot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CGM, Kobayashi S, Little MA, Mahr A, Mclaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DGI, Segelmark M, Specks U, Sunderkoetter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R
  ANN RHEUM DIS. 2010; 69: 1744-1750. IF: 8.111

• European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, VanVollenhoven RF, Ward MM, Werth VP, Carmona L
  ANN RHEUM DIS. 2010; 69: 1269-1274. IF: 8.111

Tornar